Solnatide

DB12136InvestigationalProtein Based Therapies

Solnatide has been used in trials studying the treatment of Acute Lung Injury.

Mechanism: Pharmacologically active on Epithelial sodium channel subunit alpha and Epithelial sodium channel subunit delta
Curator reviewed
Also known as: Cys-gly-gln-arg-glu-thr-pro-glu-gly-ala-glu-ala-lys-pro-trp-tyr-cys cyclic (1->17)-disulfide · L-Cysteine, L-cysteinylglycyl-L-glutaminyl-L-arginyl-L-alpha-glutamyl-L-threonyl-L-prolyl-L-alpha-glutamylglycyl-L-alanyl-L-alpha-glutamyl-L-alanyl-L-lysyl-L-prolyl-L-tryptophyl-L-tyrosyl-, cyclic (1->17)-disulfide
Code names: AP-301

Resolves to

Compound

Targets

What you can answer from here — as of July 07, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

6Clinical trialsPhase, status and sponsor resolved per trial

6+ReferencesStructured and connected to the statements they support

Which drugs share a target with Solnatide, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.